Featured News

A few highlights from research studies published in peer-reviewed journals in the last few months are products of the research grants CDF awarded.

To train a physician workforce that is better prepared to offer high-quality, patient-centric care for celiac disease, the Celiac Disease Foundation, in partnership with the Boston Children's Hospital Celiac Disease Program, is supporting a monthly case conference.

The Celiac Disease Foundation announces its newest appointee, Casey Guber, to its Board of Directors.

Join the Solutions for Celiac Study where you get access to blood testing, symptom tracking tools, and celiac specialists focused on your disease.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

A study from the University of Chicago has demonstrated that B-cells are required for the development of villous atrophy (intestinal damage) in celiac disease. This finding provides support for the exploration of B-cell–directed therapies for the treatment of celiac disease.

Celiac disease patients are at an increased risk, albeit small, of cancer, and the findings from these studies confirm the importance of a healthy immune system in cancer prevention. For patients with celiac disease, adhering to a strict, gluten-free diet is critical to maintaining a healthy immune system.

Researchers found higher rates of skin disease in patients with celiac disease compared to controls, including increased risks for eczema, psoriasis, urticaria, vitiligo, acne, and alopecia areata.

We understand the holidays can be a challenging time of year for those with celiac disease and other gluten-related disorders. Take the guesswork out of your gluten-free diet with GlutenDetect, the only at-home test to self-monitor accidental gluten exposure.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.